A. Yadav

Engineering peptide-drug conjugates for targeted cancer therapy: design principle, theranostic imaging, and translational challenges.

Peptide-drug conjugates (PDCs) are emerging as a next-generation class of targeted therapeutics designed to overcome key limitations associated with conventional chemotherapy and antibody-drug conjugates (ADCs). By integrating a tumor-homing peptide, a cleavable or stimuli-responsive linker, and a potent cytotoxic payl...